Partner Advisory | Basel, PwC Switzerland
I am a Partner leading the Health Industries consulting practice at PwC Switzerland, and have more than 20 years of experience in the Life Sciences sector.
I lead major transformation projects triggered by strategy or transaction-related initiatives, with a focus on corporate and commercial strategy, R&D, operational review, transactions and related transformation programmes.
A chemist by training with a PhD from the University of Geneva, I started my career in the Life Sciences industry – beginning in R&D and then moving on to commercial and management positions. Since I joined PwC in 2008, I have focused on providing management consulting support to leading clients in the Life Sciences industry.
Health industries M&A activity declined in the first half of 2025 compared to the prior year, as dealmakers faced mounting headwinds. While the year began with...
Dealmaking took a hit in 2024 with the number and total value of M&A deals in the Pharma & Life Science and Health Service sectors dropping to pre-2020 levels....
In this blog post, we take a look at developments in the Swiss and global M&A health care landscape and the key trends that will shape the activities in the...
Driven by innovations in biotechnology and patient services, pharma/life sciences and healthcare services continued to attract high levels of investor interest...